TWO SIGMA ADVISERS, LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 67 filers reported holding XENON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,216,984
+147.7%
64,900
+185.9%
0.01%
+200.0%
Q4 2022$895,061
-72.8%
22,700
-75.1%
0.00%
-80.0%
Q3 2022$3,285,000
+106.5%
91,000
+74.0%
0.01%
+100.0%
Q2 2022$1,591,000
-57.6%
52,300
-57.4%
0.01%
-50.0%
Q1 2022$3,751,000
-5.2%
122,700
-3.1%
0.01%0.0%
Q4 2021$3,955,000
+47.2%
126,600
-28.0%
0.01%
+42.9%
Q3 2021$2,686,000
+73.9%
175,800
+111.8%
0.01%
+75.0%
Q2 2021$1,545,000
-2.9%
83,000
-6.6%
0.00%0.0%
Q1 2021$1,591,000
+5.0%
88,900
-9.7%
0.00%0.0%
Q4 2020$1,515,000
+29.5%
98,500
-6.8%
0.00%
+33.3%
Q3 2020$1,170,000
-7.5%
105,700
+4.8%
0.00%
-25.0%
Q2 2020$1,265,000
+75.7%
100,900
+58.9%
0.00%
+33.3%
Q1 2020$720,000
+65.9%
63,500
+91.8%
0.00%
+200.0%
Q4 2019$434,000
+79.3%
33,100
+23.0%
0.00%0.0%
Q3 2019$242,000
-24.6%
26,900
-17.5%
0.00%0.0%
Q2 2019$321,000
-14.9%
32,600
-12.1%
0.00%0.0%
Q1 2019$377,000
+65.4%
37,100
+2.5%
0.00%0.0%
Q4 2018$228,00036,2000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders